CMS: anti-amyloid drug Leqembi (lecanemab) doesn’t meet the “reasonable and necessary” standard required for wider Medicare coverage

By SharpBrains | February 28, 2023

CMS Sticks to Sharply Lim­it­ed Cov­er­age of New Alzheimer’s Drug, Leqem­bi (Man­aged Health­care Exec­u­tive): For now, CMS (Note: Cen­ters for Medicare & Med­ic­aid Ser­vices) is stick­ing to the cov­er­age deci­sion it made for Aduhelm (adu­canum­ab) and apply­ing it Leqem­bi (lecanemab). The deci­sion lim­its Medicare cov­er­age of the two Alzheimer disease’s drugs to Medicare ben­e­fi­cia­ries who…

Read More

New survey highlights need to improve brain health literacy

By SharpBrains | July 3, 2015

. New Sur­vey: Sci­ence-Backed Habits Reduce Demen­tia Risk, But Many Amer­i­cans Are Mis­in­formed (Read­er’s Digest): “Reader’s Digest part­nered with the Alzheimer’s Asso­ci­a­tion to sur­vey approx­i­mate­ly 1,600 peo­ple dur­ing the month of May 2015 about their brain health and their knowl­edge of how lifestyle habits affect cog­ni­tive decline and dementia…respondents seemed to think they had more…

Read More

Brain health paradigm shift: from one-time screenings to regular cognitive assessments

By SharpBrains | April 9, 2014

USPSTF: No to Rou­tine Screen­ing for Cog­ni­tive Impair­ment (Med­scape): “There is insuf­fi­cient evi­dence to rec­om­mend rou­tine screen­ing for cog­ni­tive decline in old­er adults in the pri­ma­ry care set­ting, accord­ing to a new review by the US Pre­ven­tive Ser­vices Task Force (USPSTF)…The USPSTF review­ers looked at drug ther­a­py and non­drug ther­a­py options for cog­ni­tive impair­ment and…

Read More

Upcoming webinar: The State of the Dig­i­tal Brain Health Mar­ket (Jan­u­ary 30th, 2013)

By SharpBrains | December 27, 2012

We will dis­cuss the main find­ings and inno­va­tion opportunities/ chal­lenges iden­ti­fied in Sharp­Brains’ new mar­ket report The Dig­i­tal Brain Health Mar­ket 2012–2020: Web-based, mobile and bio­met­rics-based tech­nol­ogy to assess, mon­i­tor and enhance cog­ni­tion and brain func­tion­ing. When: Wednes­day, Jan­u­ary 30th, 2013, 1–2.30pm US East­ern Time (live webi­nar will be record­ed for lat­er view­ing by registrants)

Read More

Medicare to update reimbursement criteria for degenerative diseases such as Alzheimer’s, MS, Parkinson’s disease

By SharpBrains | October 29, 2012

What Medicare Will Cov­er Even if You’re Not Like­ly to Get Bet­ter (The New York Times): “Should the fed­er­al gov­ern­ment cov­er the costs of many kinds of treat­ments for patients who aren’t going to get any bet­ter? It didn’t, for many years. But after the set­tle­ment of a land­mark class-action this week, Medicare will soon 

Read More

Alzheimer’s Disease: is our Healthcare System Ready?

By Alvaro Fernandez | September 21, 2009 |

In the midst of much health­care reform talk, not enough atten­tion seems focused on ensur­ing health­care sys­tems’ pre­pared­ness to deal with cog­ni­tive health issues ‑with Alzheimer’s Dis­ease as the most dra­mat­ic exam­­­ple- which are pre­dict­ed to grow giv­en aging pop­u­la­tion trends. Today is World Alzheimer’s Day, and the USA Today com­ments on a new report…

Read More